AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CIPROFLOXACIN 750 Mg ;

9 registrations across 1 African market— 9 active

Markets with CIPROFLOXACIN 750 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Cipro 750 mg
Film Coated Tablets
🇪🇬EgyptMEMPHIS for pharmaceuticals and chemical industriesactive
Cipro-flox 750 mg
Film Coated Tablets
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active
Ciprofloxiraz 750 mg
Film Coated Tablets
🇪🇬EgyptNali pharma international for Pharmaceutical Industries and Tradeactive
Cipro-flox 750 mg
Film Coated Tablets
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active
Ciprofloxacin 750mg
Film Coated Tablets
🇪🇬Egyptorgano for pharmaceutical and chemical industries (organo pharma)active
Ciprofloxacin 750mg
Film Coated Tablets
🇪🇬Egyptorgano for pharmaceutical and chemical industries (organo pharma)active
Cipro 750 mg
Film Coated Tablets
🇪🇬EgyptMEMPHIS for pharmaceuticals and chemical industriesactive
Cipromax 750 mg
Film Coated Tablets
🇪🇬EgyptSpimaco-Egyptactive
Ciprofloxiraz 750 mg
Film Coated Tablets
🇪🇬EgyptNali pharma international for Pharmaceutical Industries and Tradeactive

CIPROFLOXACIN 750 Mg ; in Africa — Regulatory Overview

CIPROFLOXACIN 750 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.